发明名称 OPHTHALMIC TREATMENTS
摘要 <p>Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as hyaluronate, carbomer gel or hypromellose, together with a water-soluble analgesic. The analgesic may be an opiod, particularly an opioid having an affinity for 5-HT receptors, such as tramadol. Typical tramadol levels would be in the range of 0.5% to 1.0% w/v. The aqueous compositions may for example be used as artificial tears, and as general ophthalmic lubricants for treating conditions such as dry eye or blepharitis. Further compositions combine ophthalmologically- active agents, such as pharmaceuticals, with opioids, such as tramadol in particular. These compositions may be used to treat the eye while reducing pain or discomfort that would normally be produced by administering these particular pharmaceuticals to the eye, and increasing the efficacy of the pharmaceuticals. Compositions are also disclosed, containing opioids with 5-HT receptor activity, which are of general use in alleviating pain in and around the eye.</p>
申请公布号 TN2013000405(A1) 申请公布日期 2015.03.30
申请号 TN20130000405 申请日期 2013.10.04
申请人 OPTOSOLVE LLP 发明人 SHARMA, ANANT
分类号 A61L9/00 主分类号 A61L9/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利